Pay in 4 interest-free payments of $7.36 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
In October 2021, Kite received FDA approval for Tecartus to treat adult patients with relapsed or refractory B-cell precursor acute lymphoblastic leukemia, representing the first CAR T-cell therapy approved for adults living with this disease
The precise mechanisms for this effect are unclear
The relationship between GLP-1 receptor agonists and hair loss remains an area of ongoing investigation
Treatment of peanut allergy and colitis in mice via the intestinal release of butyrate from polymeric micelles
Toss with low-sodium soy sauce, sesame oil, rice vinegar, and sliced green onion
US$ 21.24
US$ 20.12
US$ 27.56
US$ 26.35
US$ 29.29
US$ 22.89
US$ 22.41
